Z-LVG-CHN2|CAS 119670-30-3|DC Chemicals

Cas No.:	119670-30-3
Chemical Name:	Z-LVG-CHN2
SMILES:	CC(C)[C@@H](C(N)=O)N(C([C@H](CC(C)C)NC(OCC1=CC=CC=C1)=O)=O)CC(C=[N+]=[N-])=O
Formula:	C₂₂H₃₁N₅O₅
M.Wt:	445.51
Sotrage:	Powder-20°C3 yearsIn solvent-80°C6 months-20°C1 month

Cat. No.	Product name	Field of application
DC47709	ABP 25	ABP 25 is an activity-based probe for cathepsin K imaging with excellent potency and selectivity.
DC47708	Cathepsin L-IN-2	Cathepsin L-IN-2 (Z-Phe-Phe-FMK) is a potent and irreversible cathepsin L and cathepsin B inhibitor.
DC46978	Cathepsin D and E FRET Substrate acetate	Cathepsin D and E FRET Substrate acetate is a fluorogenic substrate for cathepsins D and E and not for B, H or L. The cleavage occurs at the Phe-Phe amide bond resul. Cathepsin D and E FRET Substrate is a valuable tool for routine assays and for mechanistic studies on cathepsins E and D.
DC42335	SID 26681509 quarterhydrate	SID 26681509 quarterhydrate is a potent, reversible, competitive, and selective of human cathepsin L with an IC50 of 56 nM. SID 26681509 quarterhydrate inhibits in vitro propagation of malaria parasite Plasmodium falciparum and inhibits Leishmania major with IC50s of 15.4 μM and 12.5 μM, respectively. SID 26681509 quarterhydrate shows noy activity against cathepsin G.
DC42000	Cathepsin D and E FRET Substrate	Cathepsin D and E FRET Substrate is a fluorogenic substrate for cathepsins D and E and not for B, H or L. The cleavage occurs at the Phe-Phe amide bond resul. Cathepsin D and E FRET Substrate is a valuable tool for routine assays and for mechanistic studies on cathepsins E and D.
DC41091	VBY-825	VBY-825 is a novel, reversible cathepsin inhibitor with high potency against cathepsins B, L, S and V.
DC40098	Z-LVG-CHN2	Z-LVG-CHN2 is a cell-permeable and irreversible inhibitor of cysteine proteinase. Z-LVG-CHN2 is a tripeptide derivative and mimics part of the human cysteine proteinase-binding center. Z-LVG-CHN2 displays an inhibition on HSV whereas no significant effect on poliovirus replication. Z-LVG-CHN2 effectively blocks SARS-COV-2 replication (EC50=190 nM) via inhibition of SARS-COV-2 3CL pro protease.
DC29008	Cysteine protease inhibitor-2	Cysteine protease inhibitor-2 is a cysteine protease inhibitor extracted from patent US20070032499A1, compound 12. Cysteine protease inhibitor-2 inhibits the cells growth of DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.
DC28396	K777	K777 is a potent, orally active and irreversible cysteine protease inhibitor. K777 is also a potent CYP3A4 inhibitor with an IC50 of 60 nM and a selective CCR4 antagonist featuring the potent chemotaxis inhibition. K777 irreversibly inhibits Cruzain, the major cysteine protease of Trypansoma cruzi, and cathepsins B and L. K777 is a broad-spectrum antiviral by targeting cathepsin-mediated cell entry. K777 inhibits SARS-CoV and EBOV pseudovirus entry with IC50 values of 0.68 nM and 0.87 nM, respectively.
DC28138	JPM-OEt	JPM-OEt is a broad spectrum cysteine cathepsin inhibitor. JPM-OEt binds covalently in the active site, and irreversibly inhibits the cysteine cathepsin family. Antitumor activity.